188.78
-18.03(-8.72%)
Currency In USD
| Previous Close | 206.81 |
| Open | 196.96 |
| Day High | 198.43 |
| Day Low | 175.89 |
| 52-Week High | 212.49 |
| 52-Week Low | 93.58 |
| Volume | 901,131 |
| Average Volume | 202,981 |
| Market Cap | 3.72B |
| PE | 83.16 |
| EPS | 2.27 |
| Moving Average 50 Days | 196.75 |
| Moving Average 200 Days | 150.76 |
| Change | -18.03 |
If you invested $1000 in Ligand Pharmaceuticals Incorporated (LGND) 10 years ago, it would be worth $3,065.38 as of January 14, 2026 at a share price of $188.78. Whereas If you bought $1000 worth of Ligand Pharmaceuticals Incorporated (LGND) shares 5 years ago, it would be worth $2,474.77 as of January 14, 2026 at a share price of $188.78.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
GlobeNewswire Inc.
Dec 09, 2025 12:00 PM GMT
Introduces 2026 full year revenue guidance of $245 million to $285 million, an approximately 15% increase in core revenue growth over 2025, royalty revenue of $200 to $225 million, a 40% increase over 20251, and core adjusted earnings per diluted sha
Ligand to Participate in November Investor Conferences
GlobeNewswire Inc.
Oct 30, 2025 8:01 PM GMT
JUPITER, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investo
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 23, 2025 11:00 AM GMT
JUPITER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. The company will hold a conference call begi